Moving Toward "Precision" Medicine: Can We Tailor Diabetes Therapy to Patients' Differential Risks of Future Cardiovascular Disease?

被引：0
|
作者：
Clark, Katherine A. A. [1 ]
Morris, Alanna A. [2 ,3 ]
机构：
[1] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA
[2] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
[3] 1462 Clifton Rd,Suite 504, Atlanta, GA 30322 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2023年 / 29卷 / 03期
关键词：
HEART-FAILURE; ASSOCIATION; MELLITUS;
D O I：
10.1016/j.cardfail.2022.12.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 257
页数：3
相关论文
共 9 条
  • [1] Personality-based therapeutic choices in bipolar patients: are we moving toward precision medicine?
    Barata, B. C.
    Caixas de Sousa, R.
    Machado Nogueira, J.
    Salta, M.
    Vieira, J.
    Gomes, M.
    Freire, M. J.
    Mendes, R. S.
    Mendes, S. H.
    Gamito, A.
    BIPOLAR DISORDERS, 2016, 18 : 96 - 96
  • [2] Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
    Faridi, Kamil F.
    Desai, Nihar R.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 14
  • [3] Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine
    Sharma, Abhinav
    Zheng, Yinggan
    Ezekowitz, Justin A.
    Westerhout, Cynthia M.
    Udell, Jacob A.
    Goodman, Shaun G.
    Armstrong, Paul W.
    Buse, John B.
    Green, Jennifer B.
    Josse, Robert G.
    Kaufman, Keith D.
    McGuire, Darren K.
    Ambrosio, Giuseppe
    Chuang, Lee-Ming
    Lopes, Renato D.
    Peterson, Eric D.
    Holman, Rury R.
    DIABETES CARE, 2022, 45 (01) : 204 - 212
  • [4] Cluster analysis of cardiovascular risk phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to precision medicine
    Sharma, A.
    Zheng, Y.
    Ezekowitz, J. A.
    Westerhout, C. M.
    Goodman, S. G.
    Armstrong, P. W.
    Buse, J. B.
    Green, J. B.
    Kaufman, K. D.
    McGuire, D. K.
    Ambrosio, G.
    Chuang, L. M.
    Lopes, R. D.
    Peterson, E. D.
    Holman, R. R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 871 - 871
  • [5] Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients?
    Seely, Ellen W.
    Tsigas, Eleni
    Rich-Edwards, Janet W.
    SEMINARS IN PERINATOLOGY, 2015, 39 (04) : 276 - 283
  • [6] Clinical consequences of poor adherence to lipid-lowering therapy in patients with cardiovascular disease: can we do better?
    Klimis, Harry
    Chow, Clara K.
    HEART ASIA, 2019, 11 (02)
  • [7] Can Concurrent Fibrate Use Reduce Cardiovascular Risks among Moderate Chronic Kidney Disease Patients Undergoing Statin Therapy? A Cohort Study
    Ma, Li-Yi
    Fan, Pei-Chun
    Chen, Chao-Yu
    Tu, Yi-Ran
    Hsiao, Ching-Chung
    Yen, Chieh-Li
    Chang, Chih-Hsiang
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [8] Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias
    Chiu, Mu-Lin
    Chiou, Jian-Shiun
    Chen, Chao-Jung
    Liang, Wen-Miin
    Tsai, Fuu-Jen
    Wu, Yang-Chang
    Lin, Ting-Hsu
    Liao, Chiu-Chu
    Huang, Shao-Mei
    Chou, Chen-Hsing
    Lin, Cheng-Wen
    Li, Te-Mao
    Hsu, Yu-Lung
    Lin, Ying-Ju
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
    Chae, Young Kwang
    Arya, Ayush
    Chiec, Lauren
    Shah, Hiral
    Rosenberg, Ari
    Patel, Sandip
    Raparia, Kirtee
    Choi, Jaehyuk
    Wainwright, Derek A.
    Villaflor, Victoria
    Cristofanilli, Massimo
    Giles, Francis
    ONCOTARGET, 2017, 8 (59) : 100863 - 100898
1